| 80.89 Real-Time Quote |  +2.87 / +3.68%Today’s Change | 38.44 Today|||52-Week Range 87.47 | +93.05% Year-to-Date |
| Remember Vertex? Important Cystic Fibrosis Data On Tap Next Week Jun 06 / TheStreet.com | Investors bet on biotech success May 27 / FT.com |
| Why Idenix Is Poised to Pull Back Jun 05 / MotleyFool.com |
| Previous close | 78.02 |
| Today’s open | 77.99 |
| Day’s range | 77.98 - 80.45 |
| Volume | 636,660 |
| Average volume (3 months) | 2,471,037 |
| Market cap | $17.3B |
| Dividend yield | -- |
| Earnings growth (last year) | -457.14% |
| Earnings growth (this year) | -252.50% |
| Earnings growth (next 5 years) | +33.55% |
| Revenue growth (last year) | +8.25% |
| P/E ratio | NM |
| Price/Sales | 5.82 |
| Price/Book | 16.97 |
| Today’s change | Today’s % change | |
|---|---|---|
| SHPGShire PLC | +0.10 | +0.10% |
| ALXNAlexion Pharmaceutic... | +1.63 | +1.75% |
| ACTActavis Inc | +1.51 | +1.24% |
| ZTSZoetis Inc | -0.77 | -2.40% |
| Next reporting date | July 29, 2013 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | -$107.0M |
| Net profit margin | -7.01% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Jeff M. Leiden, PhD, MD |
Chief Financial Officer & Executive Vice President Ian F. Smith, CPA |
Corporate headquarters Cambridge, Massachusetts |
.
